Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

doi:10.1001/jamaoncol.2021.2096

Comment

. 2021 Aug 1;7(8):1123-1125.

doi: 10.1001/jamaoncol.2021.2096.

Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

Lova Sun¹, Jeremy L Warner^{2

3}, Ravi B Parikh^{1

4}

Affiliations

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.
³ Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.
⁴ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

PMID: 34047766
DOI: 10.1001/jamaoncol.2021.2096

Comment

Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

Lova Sun et al. JAMA Oncol. 2021.

. 2021 Aug 1;7(8):1123-1125.

doi: 10.1001/jamaoncol.2021.2096.

Authors

Lova Sun¹, Jeremy L Warner^{2

3}, Ravi B Parikh^{1

4}

Affiliations

¹ Perelman School of Medicine, University of Pennsylvania, Philadelphia.
² Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville, Tennessee.
³ Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee.
⁴ Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.

PMID: 34047766
DOI: 10.1001/jamaoncol.2021.2096

No abstract available

PubMed Disclaimer

Comment on

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S, Yoshida T, Kojima Y, Yagishita S, Nakahama H, Okinaka K, Matsushita H, Shiotsuka M, Kobayashi O, Iwata S, Narita Y, Ohba A, Takahashi M, Iwasa S, Kobayashi K, Ohe Y, Yoshida T, Hamada A, Doi T, Yamamoto N. Yazaki S, et al. JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159. JAMA Oncol. 2021. PMID: 34047762 Free PMC article.
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Massarweh A, Eliakim-Raz N, Stemmer A, Levy-Barda A, Yust-Katz S, Zer A, Benouaich-Amiel A, Ben-Zvi H, Moskovits N, Brenner B, Bishara J, Yahav D, Tadmor B, Zaks T, Stemmer SM. Massarweh A, et al. JAMA Oncol. 2021 Aug 1;7(8):1133-1140. doi: 10.1001/jamaoncol.2021.2155. JAMA Oncol. 2021. PMID: 34047765 Free PMC article.

Cited by

From a voluntary vaccination policy to mandatory vaccination against COVID-19 in cancer patients: an empirical and interdisciplinary study in bioethics.
Stoeklé HC, Sekkate S, Angellier E, Kennel T, Benmaziane A, Mabro M, Geay JF, Beuzeboc P, Hervé C. Stoeklé HC, et al. BMC Med Ethics. 2022 Aug 28;23(1):88. doi: 10.1186/s12910-022-00827-3. BMC Med Ethics. 2022. PMID: 36031621 Free PMC article.
COVID-19 Vaccines and Immunosuppressed Patients With Cancer: Critical Considerations.
Cazeau N, Palazzo M, Savani M, Shroff RT. Cazeau N, et al. Clin J Oncol Nurs. 2022 Jul 25;26(4):367-373. doi: 10.1188/22.CJON.367-373. Clin J Oncol Nurs. 2022. PMID: 35939727 Free PMC article.
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.
Fucà G, Lecchi M, Ciniselli CM, Ottini A, Spagnoletti A, Mazzeo L, Morelli D, Frati P, Stroscia M, Ebrahem E, Sottotetti E, Galli G, D'Elia MG, Lobefaro R, Ducceschi M, Di Guardo L, Bhoori S, Provenzano S, Platania M, Niger M, Colombo E, Nichetti F, Duca M, Rivoltini L, Mortarini R, Baili P, Apolone G, de Braud F, Verderio P, Damian S. Fucà G, et al. Ther Adv Med Oncol. 2022 Jul 27;14:17588359221108687. doi: 10.1177/17588359221108687. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35923922 Free PMC article.
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.
Yasin AI, Aydin SG, Sümbül B, Koral L, Şimşek M, Geredeli Ç, Öztürk A, Perkin P, Demirtaş D, Erdemoglu E, Hacıbekiroglu İ, Çakır E, Tanrıkulu E, Çoban E, Ozcelik M, Çelik S, Teker F, Aksoy A, Fırat ST, Tekin Ö, Kalkan Z, Türken O, Oven BB, Dane F, Bilici A, Isıkdogan A, Seker M, Türk HM, Gümüş M. Yasin AI, et al. Future Oncol. 2022 Mar;18(10):1235-1244. doi: 10.2217/fon-2021-1248. Epub 2022 Jan 27. Future Oncol. 2022. PMID: 35081732 Free PMC article.
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies.
Tamariz-Amador LE, Battaglia AM, Maia C, Zherniakova A, Guerrero C, Zabaleta A, Burgos L, Botta C, Fortuño MA, Grande C, Manubens A, Arguiñano JM, Gomez C, Perez-Persona E, Olazabal I, Oiartzabal I, Panizo C, Prosper F, San-Miguel JF, Rodriguez-Otero P, Martín-Sánchez E, Paiva B; The Asociación Vasco-Navarra de Hematología y Hemoterapia (ASOVASNA) Cooperative Group. Tamariz-Amador LE, et al. Blood Cancer J. 2021 Dec 14;11(12):202. doi: 10.1038/s41408-021-00594-1. Blood Cancer J. 2021. PMID: 34907159 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

Affiliations

Immune Responses to SARS-CoV-2 Among Patients With Cancer: What Can Seropositivity Tell Us?

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous